Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garvey

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Antimicrobial Chemotherapy|May 23, 2018
VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient miceTimothy J Break, Jigar V Desai, Kelley R Healey, et al.
Antimicrobial Agents and Chemotherapy|July 11, 2018
The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal MeningitisNathan P Wiederhold, Laura K Najvar, Edward P Garvey, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2018
<i>In Vivo</i> Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration StrategyNathan P Wiederhold, Xin Xu, Amy Wang, et al.
Antiviral Research|November 26, 2008
Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kineticsKoichiro Nakahara, Chiaki Wakasa-Morimoto, Masanori Kobayashi, et al.
Journal of Medicinal Chemistry|January 16, 2013
Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profilesTakashi Kawasuji, Brian A Johns, Hiroshi Yoshida, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2010
In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitorMasanori Kobayashi, Tomokazu Yoshinaga, Takahiro Seki, et al.
Public Health|March 3, 2020
Investigation of a foodborne outbreak of Shigella sonnei in Ireland and Northern Ireland, December 2016: the benefits of cross-border collaboration and commercial sales dataS O'Brien, P Garvey, K Baker, et al.
Epidemiology and Infection|October 14, 2014
Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapinsE B Shelley, D O'Rourke, K Grant, et al.
Journal of Medicinal Chemistry|July 13, 2013
Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)Brian A Johns, Takashi Kawasuji, Jason G Weatherhead, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 25, 2013
Investigation and management of an outbreak of Salmonella Typhimurium DT8 associated with duck eggs, Ireland 2009 to 2011P Garvey, P McKeown, P Kelly, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Antimicrobial Chemotherapy|May 23, 2018
VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient miceTimothy J Break, Jigar V Desai, Kelley R Healey, et al.
Antimicrobial Agents and Chemotherapy|July 11, 2018
The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal MeningitisNathan P Wiederhold, Laura K Najvar, Edward P Garvey, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2018
<i>In Vivo</i> Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration StrategyNathan P Wiederhold, Xin Xu, Amy Wang, et al.
Antiviral Research|November 26, 2008
Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kineticsKoichiro Nakahara, Chiaki Wakasa-Morimoto, Masanori Kobayashi, et al.
Journal of Medicinal Chemistry|January 16, 2013
Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profilesTakashi Kawasuji, Brian A Johns, Hiroshi Yoshida, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2010
In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitorMasanori Kobayashi, Tomokazu Yoshinaga, Takahiro Seki, et al.
Public Health|March 3, 2020
Investigation of a foodborne outbreak of Shigella sonnei in Ireland and Northern Ireland, December 2016: the benefits of cross-border collaboration and commercial sales dataS O'Brien, P Garvey, K Baker, et al.
Epidemiology and Infection|October 14, 2014
Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapinsE B Shelley, D O'Rourke, K Grant, et al.
Journal of Medicinal Chemistry|July 13, 2013
Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)Brian A Johns, Takashi Kawasuji, Jason G Weatherhead, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 25, 2013
Investigation and management of an outbreak of Salmonella Typhimurium DT8 associated with duck eggs, Ireland 2009 to 2011P Garvey, P McKeown, P Kelly, et al.
Pageof 13